Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | BMY | AMGN | GILD | REGN |
| Company | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 404.00 | 49.16 | 272.14 | 67.09 | 905.66 |
| High | 406.86 | 49.47 | 274.48 | 67.68 | 912.74 |
| Low | 403.47 | 48.96 | 271.05 | 67.06 | 903.83 |
| Last | 405.95 | 49.07 | 274.10 | 67.32 | 911.25 |
| Change | +6.03 | -0.07 | +2.19 | +0.37 | +11.09 |
| % Change | +1.51% | -0.14% | +0.81% | +0.55% | +1.23% |
| Volume | 464,193 | 4,637,999 | 1,345,727 | 2,656,550 | 156,045 |
| 20-Day Average Volume | 945,133 | 10,709,271 | 2,153,506 | 6,196,460 | 432,691 |
| Previous Close | 399.92 | 49.14 | 271.91 | 66.95 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 404.19 | 50.56 | 272.02 | 69.35 | 929.27 |
| 20-Day Raw Stochastic | 46.91% | 22.67% | 48.63% | 18.13% | 22.58% |
| 20-Day Relative Strength | 48.21% | 42.52% | 49.36% | 34.57% | 40.83% |
| Weighted Alpha | +17.89 | -25.37 | +11.84 | -20.34 | +14.45 |
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 40% Buy | 24% Sell | 8% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.82% since 04/16/24 | +1.89% since 04/16/24 | +3.24% since 04/16/24 | +0.05% since 04/16/24 | +1.77% since 04/16/24 |
| Low | 391.01 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 406.86 on 04/23/24 | 49.56 on 04/22/24 | 274.38 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -2.49% since 03/22/24 | -5.31% since 03/22/24 | -0.70% since 03/22/24 | -7.25% since 03/22/24 | -5.93% since 03/22/24 |
| Low | 391.01 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 421.45 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -7.83% since 01/23/24 | -1.90% since 01/23/24 | -11.51% since 01/23/24 | -15.27% since 01/23/24 | -4.68% since 01/23/24 |
| Low | 391.01 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +10.24% since 10/23/23 | -12.20% since 10/23/23 | +0.43% since 10/23/23 | -13.17% since 10/23/23 | +14.38% since 10/23/23 |
| Low | 341.90 on 11/16/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 448.40 on 01/30/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 103,362,928 | 99,594,944 | 145,845,984 | 83,357,904 | 98,803,360 |
| Shares Outstanding, K | 258,459 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 9,869,200,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | 3,619,600,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 2,517,700,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | 968,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.35 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.20 on 02/05/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/06/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 29.34 | 6.52 | 14.42 | 9.93 | 23.86 |